Document is current

Article History

Accepted: 27 September 2024

First Online: 17 October 2024

Declarations

:

: Sanofi provided the funding for the study and for the manuscript.

: C.L. is employed by Sanofi and may own Sanofi stock or stock options. During the course of the research, M.M. was employed by Sanofi and was a shareholder. Y.K. and V.P. are employed by Evidera, a part of Thermo Fisher Scientific which provides consulting and other research services to pharmaceutical, medical device, and related organizations. In their salaried positions, they work with a variety of companies and organizations and are precluded from receiving payment or honoraria directly from these organizations for services rendered. Evidera received funding from Sanofi to participate in the development of this manuscript. C.W. has received personal fees from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, CSL-Vifor, Eli Lilly and Company, GlaxoSmithKline, MSD, Novo Nordisk, and Sanofi outside the submitted work.

: Not applicable

: Not applicable

: Not applicable

: Not applicable

: C.L. and M.M. conceived the overall concept, contributed to the writing of the manuscript, provided expert review, and supervised manuscript development. V.P. conceived of the literature review design, conducted the search, and participated in the screening and data extraction. Y.K. did the majority of the writing and participated in the screening and data extraction. C.W. provided expert opinion. All authors read and approved the final manuscript.